| ECM-receptor interaction |
1.79 |
1.23e-1 |
80/88 (90.91%) |
THBS1;LAMB1;ITGA3;...
|
| DNA replication |
1.75 |
1.23e-1 |
34/36 (94.44%) |
PCNA;RFC3;MCM3;...
|
| Amoebiasis |
1.70 |
1.44e-1 |
99/102 (97.06%) |
PRKCA;GNAS;TGFB2;...
|
| Dilated cardiomyopathy |
1.61 |
2.62e-1 |
86/96 (89.58%) |
GNAS;TPM2;TGFB2;...
|
| Hypertrophic cardiomyopathy |
1.56 |
3.02e-1 |
81/90 (90%) |
TPM2;TGFB2;ATP2A2;...
|
| Small cell lung cancer |
1.55 |
3.01e-1 |
90/92 (97.83%) |
LAMB1;ITGA3;AKT3;...
|
| Proteoglycans in cancer |
1.52 |
3.23e-1 |
172/205 (83.9%) |
PRKCA;THBS1;TGFB2;...
|
| Homologous recombination |
1.52 |
2.92e-1 |
35/41 (85.37%) |
BRCC3;RAD51C;NBN;...
|
| Non-homologous end-joining |
1.50 |
3.11e-1 |
11/13 (84.62%) |
PRKDC;DCLRE1C;FEN1;...
|
| Ribosome biogenesis in eukaryotes |
1.49 |
2.85e-1 |
52/108 (48.15%) |
NOP56;HEATR1;GTPBP4;...
|
| Focal adhesion |
1.47 |
3.05e-1 |
180/201 (89.55%) |
PRKCA;THBS1;CAV2;...
|
| Hepatitis B |
1.46 |
3.10e-1 |
151/162 (93.21%) |
PRKCA;PCNA;EGR2;...
|
| RNA transport |
1.44 |
3.29e-1 |
128/186 (68.82%) |
TARDBP;NUP58;NUP62;...
|
| RNA polymerase |
1.43 |
3.41e-1 |
23/31 (74.19%) |
POLR2I;POLR1B;POLR2K;...
|
| Spliceosome |
1.42 |
3.41e-1 |
101/150 (67.33%) |
DDX42;HSPA8;HSPA1A;...
|
| Human papillomavirus infection |
1.42 |
3.35e-1 |
284/331 (85.8%) |
GNAS;THBS1;FOXO1;...
|
| Chagas disease |
1.41 |
3.17e-1 |
93/102 (91.18%) |
GNAS;C1QB;TGFB2;...
|
| Ubiquinone and other terpenoid-quinone biosynthesis |
1.41 |
3.11e-1 |
9/11 (81.82%) |
COQ2;GGCX;NQO1;...
|
| AGE-RAGE signaling pathway in diabetic complications |
1.40 |
3.20e-1 |
97/100 (97%) |
PRKCA;FOXO1;TGFB2;...
|
| Malaria |
1.40 |
3.06e-1 |
44/50 (88%) |
THBS1;TGFB2;THBS4;...
|
| Base excision repair |
1.38 |
3.37e-1 |
29/33 (87.88%) |
PCNA;PARP2;LIG1;...
|
| NF-kappa B signaling pathway |
1.37 |
3.34e-1 |
90/104 (86.54%) |
BCL2A1;RELB;CXCL1;...
|
| Nucleotide excision repair |
1.36 |
3.40e-1 |
40/47 (85.11%) |
PCNA;CETN2;GTF2H3;...
|
| Mismatch repair |
1.36 |
3.37e-1 |
22/23 (95.65%) |
PCNA;RFC3;LIG1
|
| PI3K-Akt signaling pathway |
1.35 |
3.42e-1 |
317/354 (89.55%) |
PRKCA;THBS1;GNG11;...
|
| Mannose type O-glycan biosynthesis |
1.33 |
3.83e-1 |
14/23 (60.87%) |
POMT1;FKTN;CHST10;...
|
| Rheumatoid arthritis |
1.31 |
3.87e-1 |
78/93 (83.87%) |
TGFB2;ANGPT1;CXCL1;...
|
| Hippo signaling pathway |
1.30 |
3.85e-1 |
120/186 (64.52%) |
ID1;TGFB2;RASSF2;...
|
| Toxoplasmosis |
1.29 |
3.87e-1 |
103/112 (91.96%) |
TGFB2;LAMB1;HSPA8;...
|
| Parathyroid hormone synthesis, secretion and action |
1.28 |
3.94e-1 |
98/106 (92.45%) |
PRKCA;PTHLH;GNAS;...
|
| T cell receptor signaling pathway |
-1.32 |
4.12e-1 |
93/104 (89.42%) |
PAK3;NFKBIB;BCL10;...
|
| Porphyrin and chlorophyll metabolism |
-1.32 |
4.12e-1 |
23/43 (53.49%) |
COX15;HMOX2;UGT2B15;...
|
| Synaptic vesicle cycle |
-1.32 |
4.12e-1 |
63/78 (80.77%) |
SLC1A6;CACNA1B;SLC6A11;...
|
| Bile secretion |
-1.33 |
4.19e-1 |
68/90 (75.56%) |
SCARB1;HMGCR;SLC5A1;...
|
| Selenocompound metabolism |
-1.34 |
3.95e-1 |
11/17 (64.71%) |
SCLY;CTH;SEPHS2
|
| Amino sugar and nucleotide sugar metabolism |
-1.34 |
4.03e-1 |
38/48 (79.17%) |
HEXA;PGM1;GFPT1;...
|
| Glycine, serine and threonine metabolism |
-1.35 |
4.04e-1 |
31/40 (77.5%) |
PHGDH;GLDC;GATM;...
|
| Graft-versus-host disease |
-1.35 |
4.19e-1 |
32/42 (76.19%) |
FAS;KLRD1;GZMB;...
|
| D-Glutamine and D-glutamate metabolism |
-1.39 |
3.76e-1 |
5/5 (100%) |
GLS;GLUD1
|
| Estrogen signaling pathway |
-1.39 |
3.71e-1 |
119/137 (86.86%) |
KRT19;PIK3CB;GNAQ;...
|
| Glioma |
-1.39 |
3.89e-1 |
67/75 (89.33%) |
PIK3CB;BAK1;PDGFRB;...
|
| Biosynthesis of unsaturated fatty acids |
-1.40 |
3.82e-1 |
21/27 (77.78%) |
TECR;SCD5;ACOT7;...
|
| Staphylococcus aureus infection |
-1.41 |
3.96e-1 |
72/95 (75.79%) |
ITGAL;ITGB2;HLA-DQB1;...
|
| Vitamin digestion and absorption |
-1.43 |
3.54e-1 |
17/24 (70.83%) |
MMACHC;SLC19A2;LMBRD1;...
|
| Phototransduction |
-1.46 |
2.99e-1 |
21/29 (72.41%) |
CALML5;CALML4
|
| Central carbon metabolism in cancer |
-1.47 |
2.73e-1 |
67/70 (95.71%) |
SLC7A5;PFKP;GLS;...
|
| PPAR signaling pathway |
-1.50 |
2.44e-1 |
66/74 (89.19%) |
DBI;CD36;FABP7;...
|
| Fat digestion and absorption |
-1.53 |
1.89e-1 |
35/43 (81.4%) |
APOA4;PLPP1;CLPS;...
|
| Protein digestion and absorption |
-1.54 |
1.98e-1 |
78/103 (75.73%) |
FXYD2;MEP1B;ATP1B1;...
|
| Glycolysis / Gluconeogenesis |
-1.55 |
1.86e-1 |
56/67 (83.58%) |
MINPP1;ADH6;PKM;...
|
| Histidine metabolism |
-1.55 |
2.04e-1 |
16/22 (72.73%) |
HNMT;ALDH9A1;HAL;...
|
| Nicotinate and nicotinamide metabolism |
-1.56 |
2.18e-1 |
25/35 (71.43%) |
SIRT6;SIRT1;ENPP1;...
|
| Arginine biosynthesis |
-1.58 |
2.05e-1 |
17/22 (77.27%) |
ARG1;GOT2;GLUL;...
|
| Thyroid cancer |
-1.62 |
1.59e-1 |
36/37 (97.3%) |
GADD45G;TCF7L1;BAK1;...
|
| Peroxisome |
-1.62 |
1.73e-1 |
72/82 (87.8%) |
PAOX;PIPOX;PEX16;...
|
| Protein processing in endoplasmic reticulum |
-1.65 |
1.56e-1 |
127/171 (74.27%) |
RPN1;SEC61B;STT3A;...
|
| Renin-angiotensin system |
-1.65 |
1.96e-1 |
20/23 (86.96%) |
CTSG;AGTR1;ATP6AP2;...
|
| Ascorbate and aldarate metabolism |
-1.78 |
5.22e-2 |
15/30 (50%) |
RGN;UGT2B15;AKR1A1;...
|
| Nitrogen metabolism |
-1.78 |
7.82e-2 |
16/17 (94.12%) |
CA14;CA6;GLUD1;...
|
| Arginine and proline metabolism |
-1.80 |
1.37e-1 |
39/50 (78%) |
PRODH;GATM;CKB;...
|
